1. Home
  2. Service & Software
  3. Global Intramuscular Drug Delivery Market Status and Forecast 2021-2027

Global Intramuscular Drug Delivery Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 128 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Intramuscular Drug Delivery market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Intramuscular Drug Delivery industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Intramuscular Drug Delivery market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Intramuscular Drug Delivery Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Intramuscular Drug Delivery market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Intramuscular Drug Delivery Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Intramuscular Drug Delivery industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Drug Molecule
Delivery Devices

Segmented by Application
Infectious Disease
Oncology
Autoimmune Diseases

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva Pharmaceutical
Pharmajet
Pfizer
Pacira Pharmaceuticals
Novartis
Merck
Inovio Pharmaceuticals
HMD pharmaceuticals
Galaxo
Eli Lily
Antares Pharma


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Intramuscular Drug Delivery Market Status and Forecast (2016-2027)
1.3.2 Global Intramuscular Drug Delivery Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Intramuscular Drug Delivery Supply by Company
2.1 Global Intramuscular Drug Delivery Sales Value by Company
2.2 Intramuscular Drug Delivery Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Intramuscular Drug Delivery Market Status by Type
3.1 Intramuscular Drug Delivery Type Introduction
3.1.1 Drug Molecule
3.1.2 Delivery Devices
3.2 Global Intramuscular Drug Delivery Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Intramuscular Drug Delivery Market Status by Application
4.1 Intramuscular Drug Delivery Segment by Application
4.1.1 Infectious Disease
4.1.2 Oncology
4.1.3 Autoimmune Diseases
4.2 Global Intramuscular Drug Delivery Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Intramuscular Drug Delivery Market Status by Region
5.1 Global Intramuscular Drug Delivery Market by Region
5.2 North America Intramuscular Drug Delivery Market Status
5.3 Europe Intramuscular Drug Delivery Market Status
5.4 Asia Pacific Intramuscular Drug Delivery Market Status
5.5 Central & South America Intramuscular Drug Delivery Market Status
5.6 Middle East & Africa Intramuscular Drug Delivery Market Status
6 North America Intramuscular Drug Delivery Market Status
6.1 North America Intramuscular Drug Delivery Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Intramuscular Drug Delivery Market Status
7.1 Europe Intramuscular Drug Delivery Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Intramuscular Drug Delivery Market Status
8.1 Asia Pacific Intramuscular Drug Delivery Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Intramuscular Drug Delivery Market Status
9.1 Central & South America Intramuscular Drug Delivery Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Intramuscular Drug Delivery Market Status
10.1 Middle East & Africa Intramuscular Drug Delivery Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Intramuscular Drug Delivery Market Forecast by Type and by Application
12.1 Global Intramuscular Drug Delivery Sales Value Forecast (2022-2027)
12.2 Global Intramuscular Drug Delivery Forecast by Type
12.3 Global Intramuscular Drug Delivery Forecast by Application
13 Global Intramuscular Drug Delivery Market Forecast by Region/Country
13.1 Global Intramuscular Drug Delivery Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva Pharmaceutical
14.1.1 Company Information
14.1.2 Intramuscular Drug Delivery Product Introduction
14.1.3 Teva Pharmaceutical Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Pharmajet
14.2.1 Company Information
14.2.2 Intramuscular Drug Delivery Product Introduction
14.2.3 Pharmajet Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Pfizer
14.3.1 Company Information
14.3.2 Intramuscular Drug Delivery Product Introduction
14.3.3 Pfizer Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Pacira Pharmaceuticals
14.4.1 Company Information
14.4.2 Intramuscular Drug Delivery Product Introduction
14.4.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Novartis
14.5.1 Company Information
14.5.2 Intramuscular Drug Delivery Product Introduction
14.5.3 Novartis Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Merck
14.6.1 Company Information
14.6.2 Intramuscular Drug Delivery Product Introduction
14.6.3 Merck Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Inovio Pharmaceuticals
14.7.1 Company Information
14.7.2 Intramuscular Drug Delivery Product Introduction
14.7.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 HMD pharmaceuticals
14.8.1 Company Information
14.8.2 Intramuscular Drug Delivery Product Introduction
14.8.3 HMD pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Galaxo
14.9.1 Company Information
14.9.2 Intramuscular Drug Delivery Product Introduction
14.9.3 Galaxo Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Eli Lily
14.10.1 Company Information
14.10.2 Intramuscular Drug Delivery Product Introduction
14.10.3 Eli Lily Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Antares Pharma
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Intramuscular Drug Delivery Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Intramuscular Drug Delivery Sales Value (Million USD) by Company (2019-2021)
Table Global Intramuscular Drug Delivery Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Intramuscular Drug Delivery Sales Area
Table Intramuscular Drug Delivery Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table Global Intramuscular Drug Delivery Sals Value Market Share by Type (2016-2021)
Table North America Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table North America Intramuscular Drug Delivery Sales Value Market Share by Type (2016-2021)
Table Europe Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table Europe Intramuscular Drug Delivery Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Sales Value Market Share by Type (2016-2021)
Table Central & South America Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Intramuscular Drug Delivery Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Sales Value Market Share by Type (2016-2021)
Table Global Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table Global Intramuscular Drug Delivery Value Market Share by Application (2016-2021)
Table North America Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table North America Intramuscular Drug Delivery Sales Value Market Share by Application (2016-2021)
Table Europe Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table Europe Intramuscular Drug Delivery Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Sales Value Market Share by Application (2016-2021)
Table Central & South America Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Intramuscular Drug Delivery Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Sales Value Market Share by Application (2016-2021)
Table Global Intramuscular Drug Delivery Sales Value (Million USD) by Region (2016-2021)
Table Global Intramuscular Drug Delivery Value Market Share by Region (2016-2021)
Table North America Intramuscular Drug Delivery Sales Value (Million USD) by Country (2016-2021)
Table North America Intramuscular Drug Delivery Value Market Share by Country (2016-2021)
Table Europe Intramuscular Drug Delivery Sales Value (Million USD) by Country (2016-2021)
Table Europe Intramuscular Drug Delivery Value Market Share by Country (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Intramuscular Drug Delivery Value Market Share by Country (2016-2021)
Table Central & South America Intramuscular Drug Delivery Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Intramuscular Drug Delivery Value Market Share by Country (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Intramuscular Drug Delivery Value Market Share by Country (2016-2021)
Table Global Intramuscular Drug Delivery Value (Million USD) Forecast by Type (2022-2027)
Table Global Intramuscular Drug Delivery Value Market Share Forecast by Type (2022-2027)
Table Global Intramuscular Drug Delivery Value (Million USD) Forecast by Application (2022-2027)
Table Global Intramuscular Drug Delivery Value Market Share Forecast by Application (2022-2027)
Table Global Intramuscular Drug Delivery Value (Million USD) Forecast by Region (2022-2027)
Table Global Intramuscular Drug Delivery Value Market Share Forecast by Region (2022-2027)
Table Teva Pharmaceutical Company Information
Table Teva Pharmaceutical Product Introduction
Table Teva Pharmaceutical Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Pharmajet Company Information
Table Pharmajet Product Introduction
Table Pharmajet Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Pacira Pharmaceuticals Company Information
Table Pacira Pharmaceuticals Product Introduction
Table Pacira Pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Merck Company Information
Table Merck Product Introduction
Table Merck Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Inovio Pharmaceuticals Company Information
Table Inovio Pharmaceuticals Product Introduction
Table Inovio Pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table HMD pharmaceuticals Company Information
Table HMD pharmaceuticals Product Introduction
Table HMD pharmaceuticals Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Galaxo Company Information
Table Galaxo Product Introduction
Table Galaxo Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)
Table Eli Lily Company Information
Table Eli Lily Product Introduction
Table Eli Lily Intramuscular Drug Delivery Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Service & Software Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Service & Software Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets